The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/19718
StudyName: Eligibility Breast Neoplasms NCT02307227
Date of export from the portal: 02.07.2020
Date of Upload / last change: 23.01.2017
License: Creative Commons BY 4.0

----

Description: 
Phase II Study With Trastuzumab + Paclitaxel in Locally Advanced HER2+ Tumors or Epirubicin + Taxotere in HER2- Tumors; ODM derived from: https://clinicaltrials.gov/show/NCT02307227
